What is your approach for using anticoagulation/aspirin in patients with multiple myeloma?
2
2 AnswersMednet Member
Medical Oncology · University of Washington, Fred Hutchinson Cancer Research Center
Excellent question with lots of nuances but no clear answer. I'll start with my gestalt approach, which is to consider a DOAC for every patient with myeloma if all of the following are true:
- They are receiving an IMiD (lenalidomide or pomalidomide)
- They set off my 'spidey sense' with one or more of ...
Mednet Member
Medical Oncology · University of Chicago
@Dr. First Last has done a wonderful job here.
My practice is to start a prophylactic dose DOAC (apixaban 2.5 mg BID, rivaroxaban 10 mg daily) for essentially all patients with newly diagnosed myeloma. This is in part because we frequently employ quadruplets and/or cafilzomib-based regimens. I tran...